US equities |
MU $1,068.29 ▼-1.81% NVDA $236.62 ▼-0.36% PLTR $199.93 ▲+2.99% SNDK $1,647.40 ▼-2.66% AMD $636.80 ▼-1.40% INTC $109.57 ▼-3.14% META $721.48 ▲+0.02% SPCX $164.47 ▼-1.86%
FinancialContent

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

0.4211 -0.0083 (-1.93%)
Delayed Quote Updated: 10:50 AM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ensysce Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam
Via ACCESS Newswire
News headline image
Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study
Via ACCESS Newswire
News headline image
These stocks are moving in today's after hours session ↗
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs
Via ACCESS Newswire
News headline image
Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results
Via ACCESS Newswire
Which stocks are moving on Wednesday? ↗
Via Chartmill
News headline image
Ensysce Biosciences Initiates Live "Ask Me Anything" (AMA) Session Highlighting Growth and Future Plans
Via ACCESS Newswire
News headline image
Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology
Via ACCESS Newswire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Top movers in Friday's after hours session ↗
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Discover the most active stocks in Friday's session. ↗
Via Chartmill
News headline image
Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) Advances QuickStrip™ Research Backed by NFL-Supported Clinical Evaluation – More Stocks Inside
Via AB Newswire
Which stocks are moving on Friday? ↗
Via Chartmill
Gapping stocks in Friday's session ↗
Via Chartmill
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
Ensysce Biosciences Initiates Review of Strategic Alternatives to Enhance Shareholder Value
Via ACCESS Newswire
News headline image
Ensysce Biosciences Invited to Participate in Upcoming Scientific and Industry Events
Via ACCESS Newswire
Unusual volume stocks are being observed in Wednesday's session. ↗
Via Chartmill
Which stocks have an unusual volume on Tuesday? ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
Here are the top movers in Tuesday's session. ↗
Via Chartmill
These stocks are gapping in today's session ↗
Via Chartmill
Top movers in Tuesday's pre-market session ↗
Via Chartmill
Monday's after hours session: top gainers and losers ↗
Via Chartmill
News headline image
Ensysce Biosciences Expands Global Opioid Patent Portfolio
Via ACCESS Newswire
News headline image
Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection
Via ACCESS Newswire
News headline image
Ensysce Biosciences Issues Annual Shareholder Letter
Via ACCESS Newswire
News headline image
Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >